GenusPlus Group Zukünftiges Wachstum
Future Kriterienprüfungen 6/6
GenusPlus Group wird ein jährliches Gewinn- und Umsatzwachstum von 35.2% bzw. 28.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 29% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.7% betragen.
Wichtige Informationen
35.2%
Wachstumsrate der Gewinne
28.97%
EPS-Wachstumsrate
| Construction Gewinnwachstum | 17.0% |
| Wachstumsrate der Einnahmen | 28.2% |
| Zukünftige Eigenkapitalrendite | 21.72% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 27 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
GNP: Index Removal And Refined Assumptions Will Shape Balanced Future Outlook
Analysts have nudged their price target for GenusPlus Group higher to A$9.99 from A$9.50, pointing to updated assumptions around revenue growth, profit margins and future P/E that support a slightly richer valuation profile. What's in the News GenusPlus Group Ltd was removed from the S&P/ASX Emerging Companies Index.GNP: Index Removal And Steady Assumptions Will Support Future Upside
Analysts have kept their price target for GenusPlus Group broadly steady at around A$9.50, citing only minor adjustments to inputs such as the discount rate, expected revenue growth, profit margin and future P/E assumptions. What's in the News GenusPlus Group Ltd was removed from the S&P/ASX Emerging Companies Index.GNP: Stable Assumptions And Index Removal Will Support Future Upside
Analysts have maintained their A$9.50 price target for GenusPlus Group, citing only marginal adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E that are not material enough to change their overall valuation view. What's in the News GenusPlus Group Ltd was removed from the S&P/ASX Emerging Companies Index.GNP: Higher Revenue Assumptions And Margin Gains Will Support Future Upside
Analysts have lifted their price target for GenusPlus Group from A$8.94 to A$9.50, citing updated assumptions for revenue growth, profit margins and a slightly lower discount rate, alongside a modestly reduced future P/E multiple. Valuation Changes Fair Value: A$8.94 to A$9.50, indicating a modest uplift in the central valuation estimate.GNP: Lower Discount Rate And Stable P/E Will Support Future Upside
Analysts have lifted their price target for GenusPlus Group from A$8.71 to A$8.94, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations. Valuation Changes Fair Value: A$8.71 to A$8.94, risen slightly on the updated assumptions.GNP: Stable Margin And P/E Assumptions Will Support Future Upside
Analysts have maintained their price target for GenusPlus Group at A$8.71, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E that they see as better capturing the company’s current risk and earnings profile. Valuation Changes Fair Value: A$8.71 remains unchanged, indicating no adjustment to the central valuation outcome.Earnings Not Telling The Story For GenusPlus Group Ltd (ASX:GNP) After Shares Rise 25%
GenusPlus Group Ltd ( ASX:GNP ) shareholders would be excited to see that the share price has had a great month...GNP: Higher Assumed Margins And P/E Will Support Future Share Upside
Analysts have lifted their price target for GenusPlus Group to A$8.71, up from A$6.50, citing updates to their models that incorporate revised assumptions for discount rates, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: Updated from A$6.50 to A$8.71, a sizeable uplift in the modelled estimate.GNP: Elevated P/E And Margins Will Likely Restrain Future Share Returns
Analysts have kept their fair value estimate for GenusPlus Group steady at A$6.50, with only minor tweaks to assumptions such as discount rate, long term revenue growth, profit margin and future P/E informing this unchanged price target view. Valuation Changes Fair Value Estimate: unchanged at A$6.50 per share, reflecting a stable overall valuation view.GNP: Index Inclusion And Stable Metrics Will Support Balanced Future Share Performance
Analysts have maintained their fair value estimate for GenusPlus Group at A$6.50, citing only minor technical adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions that do not materially change their overall price target view. Valuation Changes Fair Value Estimate: unchanged at A$6.50 per share.GNP: Index Inclusion And Stable Outlook Will Support Balanced Share Performance
Analysts have raised their price target for GenusPlus Group from A$5.75 to A$6.50, reflecting slightly higher assumed revenue growth, modestly improved profit margins, and a richer future earnings multiple despite a marginally higher discount rate. What's in the News GenusPlus Group Ltd (ASX:GNP) has been added to the S&P Global BMI Index.GenusPlus Group Ltd's (ASX:GNP) Shares May Have Run Too Fast Too Soon
With a price-to-earnings (or "P/E") ratio of 31.3x GenusPlus Group Ltd ( ASX:GNP ) may be sending very bearish signals...Do GenusPlus Group's (ASX:GNP) Earnings Warrant Your Attention?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...HumeLink And CommTel Acquisitions Will Transform Operations
The upward revision of GenusPlus Group’s price target appears driven by a notably higher future P/E multiple despite a slight decline in net profit margin, raising fair value from A$4.70 to A$5.75. What's in the News Announced annual dividend of AUD 0.0360 per share, payable on October 31, 2025.Investors Appear Satisfied With GenusPlus Group Ltd's (ASX:GNP) Prospects As Shares Rocket 27%
GenusPlus Group Ltd ( ASX:GNP ) shares have continued their recent momentum with a 27% gain in the last month alone...GenusPlus Group Ltd's (ASX:GNP) P/E Is Still On The Mark Following 29% Share Price Bounce
GenusPlus Group Ltd ( ASX:GNP ) shareholders would be excited to see that the share price has had a great month...HumeLink And CommTel Acquisitions Will Transform Operations
Strategic acquisitions and project awards signal potential revenue diversification and growth in future net margins and profitability.Pinning Down GenusPlus Group Ltd's (ASX:GNP) P/E Is Difficult Right Now
GenusPlus Group Ltd's ( ASX:GNP ) price-to-earnings (or "P/E") ratio of 21.7x might make it look like a sell right now...Estimating The Intrinsic Value Of GenusPlus Group Limited (ASX:GNP)
Key Insights The projected fair value for GenusPlus Group is AU$2.26 based on 2 Stage Free Cash Flow to Equity With...Does GenusPlus Group (ASX:GNP) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Is GenusPlus Group Limited (ASX:GNP) Trading At A 30% Discount?
Key Insights The projected fair value for GenusPlus Group is AU$2.21 based on 2 Stage Free Cash Flow to Equity...Market Still Lacking Some Conviction On GenusPlus Group Limited (ASX:GNP)
With a median price-to-earnings (or "P/E") ratio of close to 19x in Australia, you could be forgiven for feeling...GenusPlus Group's (ASX:GNP) Robust Profit May Be Overstating Its True Earnings Potential
Shareholders were pleased with the recent earnings report from GenusPlus Group Limited ( ASX:GNP ). Investors should be...Estimating The Intrinsic Value Of GenusPlus Group Limited (ASX:GNP)
In this article we are going to estimate the intrinsic value of GenusPlus Group Limited ( ASX:GNP ) by taking the...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2028 | 1,886 | 106 | 131 | 164 | 2 |
| 6/30/2027 | 1,786 | 102 | 123 | 162 | 2 |
| 6/30/2026 | 1,116 | 51 | 86 | 113 | 2 |
| 12/31/2025 | 954 | 47 | 152 | 170 | N/A |
| 9/30/2025 | 853 | 41 | 130 | 146 | N/A |
| 6/30/2025 | 751 | 35 | 108 | 121 | N/A |
| 3/31/2025 | 693 | 30 | 89 | 104 | N/A |
| 12/31/2024 | 634 | 24 | 70 | 88 | N/A |
| 9/30/2024 | 593 | 22 | 69 | 85 | N/A |
| 6/30/2024 | 551 | 19 | 69 | 83 | N/A |
| 3/31/2024 | 510 | 18 | 52 | 64 | N/A |
| 12/31/2023 | 470 | 16 | 35 | 44 | N/A |
| 9/30/2023 | 457 | 15 | 34 | 42 | N/A |
| 6/30/2023 | 444 | 13 | 33 | 39 | N/A |
| 3/31/2023 | 452 | 12 | 25 | 30 | N/A |
| 12/31/2022 | 459 | 11 | 17 | 20 | N/A |
| 9/30/2022 | 455 | 12 | 12 | 16 | N/A |
| 6/30/2022 | 451 | 14 | 7 | 11 | N/A |
| 3/31/2022 | 424 | 15 | 6 | 14 | N/A |
| 12/31/2021 | 397 | 17 | 6 | 17 | N/A |
| 9/30/2021 | 357 | 15 | 1 | 12 | N/A |
| 6/30/2021 | 318 | 13 | -4 | 7 | N/A |
| 3/31/2021 | 270 | 11 | 4 | 13 | N/A |
| 12/31/2020 | 222 | 9 | 13 | 20 | N/A |
| 9/30/2020 | 196 | 10 | 21 | 29 | N/A |
| 6/30/2020 | 170 | 11 | 30 | 37 | N/A |
| 6/30/2019 | 100 | 6 | N/A | 4 | N/A |
| 6/30/2018 | 12 | 0 | N/A | 2 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: GNPDas prognostizierte Gewinnwachstum (35.2% pro Jahr) liegt über der Sparquote (3.6%).
Ertrag vs. Markt: GNPDie Erträge des Unternehmens (35.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (12% pro Jahr).
Hohe Wachstumserträge: GNPEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: GNPDie Einnahmen des Unternehmens (28.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (6.1% pro Jahr).
Hohe Wachstumseinnahmen: GNPDie Einnahmen des Unternehmens (28.2% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: GNPDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.7%)
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/29 16:26 |
| Aktienkurs zum Tagesende | 2026/05/29 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/06/30 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
GenusPlus Group Ltd wird von 3 Analysten beobachtet. 2 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Steven Anastasiou | Bell Potter |
| Joseph House | Bell Potter |
| Matthew Chen | MA Moelis Australia Securities Pty Ltd |